Epidemiology Resources

Published in 2016, this report provides an overview of the programmes available to tackle the rise of type 2 diabetes. The wide range of options presented and their cost-saving implications give cause for optimism that the current situation can be reversed.

The RWE (Real World Evidence) Box is the iCaReMe registry data capture, management and analytics tool. It enables clinical, medical and real-world evidence research.

This guideline explains step-by-step how to use the iCaReMe electronic case report forms (CRF), which gives real-world data for healthcare professionals on patient management and quality of care.

Take CaReofMe is a subset of the iCaReMe registry. It is an initial study on the gaps in early diagnosis of cardiorenal complications among people with type 2 diabetes from six countries.

These posters from 2021 - 2023 present data findings from the iCaReMe study.

The iCaReMe registry is the continuation of the DISCOVER Global Registry (DGR) with an expansion on cardio-renal complications. DGR provides valuable insight into people with type 2 diabetes undergoing treatment in clinical practice. This registry helps to understand the patterns and effects of treatment approaches on cardio-renal-metabolic multimorbidities. It also aims to increase the real-world evidence base established by the DISCOVER study.